Citadel Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.13M Sell
40,000
-15,200
-28% -$893K ﹤0.01% 5938
2025
Q4
$3.43M Buy
55,200
+21,800
+65% +$1.35M ﹤0.01% 4918
2025
Q3
$2.01M Buy
33,400
+4,500
+16% +$275K ﹤0.01% 6054
2025
Q2
$1.81M Buy
28,900
+6,200
+27% +$373K ﹤0.01% 5884
2025
Q1
$1.37M Sell
22,700
-38,000
-63% -$2.36M ﹤0.01% 6273
2024
Q4
$3.54M Sell
60,700
-29,000
-32% -$1.72M ﹤0.01% 4555
2024
Q3
$5.31M Sell
89,700
-36,700
-29% -$2.1M ﹤0.01% 3839
2024
Q2
$7.08M Sell
126,400
-39,200
-24% -$2.19M ﹤0.01% 3255
2024
Q1
$9.7M Buy
165,600
+5,000
+3% +$282K ﹤0.01% 2988
2023
Q4
$8.67M Buy
160,600
+71,800
+81% +$3.51M ﹤0.01% 3041
2023
Q3
$4.31M Buy
88,800
+6,100
+7% +$324K ﹤0.01% 3904
2023
Q2
$4.67M Sell
82,700
-20,600
-20% -$1.13M ﹤0.01% 3748
2023
Q1
$5.58M Sell
103,300
-81,300
-44% -$4.33M ﹤0.01% 3624
2022
Q4
$9.7M Buy
184,600
+21,200
+13% +$1.08M ﹤0.01% 2884
2022
Q3
$7.71M Buy
163,400
+20,700
+15% +$1.07M ﹤0.01% 3144
2022
Q2
$7.2M Buy
142,700
+24,900
+21% +$1.36M ﹤0.01% 3156
2022
Q1
$7.18M Buy
117,800
+36,500
+45% +$2.18M ﹤0.01% 3505
2021
Q4
$5.35M Buy
81,300
+600
+0.7% +$38.4K ﹤0.01% 4171
2021
Q3
$5.07M Sell
80,700
-50,700
-39% -$3.23M ﹤0.01% 4268
2021
Q2
$7.91M Buy
131,400
+44,400
+51% +$2.57M ﹤0.01% 3517
2021
Q1
$4.79M Buy
87,000
+77,400
+806% +$4.29M ﹤0.01% 4351
2020
Q4
$524K Buy
+9,600
New +$502K ﹤0.01% 8059

Other funds holding IHI

Citadel Advisors's IHI Position: Q1 2026 in Review

Citadel Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 49,552 shares — an estimated $2.91M sold.

Citadel Advisors first reported a position in IHI in Q4 2014 and held it in 31 quarters. The position peaked at $12.1M in Q1 2024. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Citadel Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 49,552 iShares US Medical Devices ETF shares in Q1 2026, an estimated $2.91M.
  • Citadel Advisors first reported a position in iShares US Medical Devices ETF in Q4 2014 and held it in 31 quarters.
  • Citadel Advisors's iShares US Medical Devices ETF position peaked at $12.1M in Q1 2024.
  • 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.